Reviva Pharmaceuticals
OTC: RVPHSanta Clara, US · Founded 2018 · Delaware corporation · 1 known investors
Clinical-stage pharmaceutical company developing innovative therapies
Biotech
Founders & leadership
LB
Laxminarayan BhatExecutive Officer, Director
MC
Marc CantillonExecutive Officer
SD
Sarvajna DwivediDirector
PJ
Pedr JensenDirector
PP
Purav PatelDirector
NP
Narayan PrabhuExecutive Officer
LF
Les FuntleyderDirector
RM
Richard MargolinDirector
PS
Parag SaxenaDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶Undisclosed amountofferedSep 2022 · 3 investors · PharmaceuticalsRule 506(b)
▶Undisclosed amountofferedSep 2022 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Purav PatelDirector
- Narayan PrabhuExecutive Officer
- Parag SaxenaDirector
- Les FuntleyderDirector
- Richard MargolinDirector
- Laxminarayan BhatExecutive Officer, Director
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.2MraisedJul 2016 · 16 investors · PharmaceuticalsRule 506(c)
▶$1.2MraisedJul 2016 · 16 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Laxminarayan BhatExecutive Officer, Director
- Marc CantillonExecutive Officer
- Sarvajna DwivediDirector
- Pedr JensenDirector
- Offering amount
- $5M
- Amount sold
- $1.2M
- Minimum investment
- $25K
- Sales commissions
- $150K
- Placement agents
- Rodman & Renshaw, a unit of H.C. Wainwright & Co, LLC
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.